Immunome

Immunome

Immunome - Novel Immunotherapies for Cancer.

HQ location
Upper Merion Township, United States
Launch date
Employees
Market cap
$866m
Enterprise value
$602m
Share price
$9.90 IMNM
Recent deals
  • Edit
Get premium to view all results
DateInvestorsAmountRound
investor

€0.0

round
N/A

€0.0

round
investor

€0.0

round
N/A

€0.0

round
N/A

€0.0

round
investor

€0.0

round
investor

€0.0

round
investor investor

€0.0

round
N/A

€0.0

round
N/A

€0.0

round
investor

€0.0

round
N/A

€0.0

round
N/A

€0.0

round
investor investor investor investor investor investor

€0.0

round
N/A

€0.0

round
*
N/A

$173m

Post IPO Equity
Total Funding000k

Financials

Estimates*

Get premium to view all results
Edit
Revenues, earnings & profits over time
USD2021202220232024202520262027
Revenues0000000000000000000000000000
% growth---(36 %)(19 %)111 %359 %
EBITDA0000000000000000000000000000
% EBITDA margin--377 %11 %---
Profit0000000000000000000000000000
% profit margin--(762 %)(3240 %)(2554 %)(1432 %)(303 %)
EV0000000000000000000000000000
EV / revenue00.0x00.0x00.0x00.0x00.0x00.0x00.0x
EV / EBITDA00.0x00.0x00.0x00.0x00.0x00.0x00.0x
R&D budget0000000000000000000000000000
R&D % of revenue--165 %1433 %---

Source: Company filings or news article, Equity research estimates

Notes (0)
More about Immunome
Made with AI
Edit

Immunome is a biotechnology company focused on developing first-in-class therapeutics by harnessing the power of the immune system. The company operates in the biopharmaceutical market and serves clients in the healthcare and medical research sectors. Immunome's proprietary discovery platform identifies novel therapeutic antibodies and their targets by analyzing the immune systems of patients who have successfully fought off diseases. This approach aims to create groundbreaking treatments for various conditions. The business model revolves around research and development, with revenue generated through partnerships, licensing agreements, and potential future sales of approved therapies. Immunome's team includes experts in clinical oncology and medical research, ensuring a strong foundation for scientific innovation.

Keywords: biotechnology, therapeutics, immune system, antibodies, biopharmaceutical, healthcare, medical research, discovery platform, oncology, innovation.

Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.
Book a Demo

Investments by Immunome

Edit
Morphimmune
ACQUISITION by Immunome Jun 2023